The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
Author:
Funder
MSc in Transltional Oncology at Trinity College Dublin
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference233 articles.
1. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer;Katso;Annu Rev Cell Dev Biol.,2001
2. The phosphatidylinositol 3-kinase AKT pathway in human cancer;Vivanco;Nat Rev Cancer.,2002
3. AKT signalling in normal and malignant cells;Testa;Oncogene.,2005
4. AKT/PKB signalling: navigating downstream;Manning;Cell.,2007
5. Targetting PI3K signalling in cancer: opportunities, challenges and limitations;Engelman;Nat Rev Cancer.,2009
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies;Bioorganic Chemistry;2024-07
2. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy;Journal of Controlled Release;2024-03
3. Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis;Frontiers in Pharmacology;2024-01-04
4. Innovative Drug Delivery Systems for Drug-Resistant Breast Cancer;Overcoming Breast Cancer Therapy Resistance;2024
5. Safety and Toxicology Study of Hu7691, a Novel AKT Inhibitor, following Oral Administration in Rats;Toxics;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3